HealthEquity, Inc. provided earnings guidance for the fiscal year ending January 31, 2023. For the year, the management expects revenues of $834 million to $844 million. Its outlook for net loss is between $43 million and $36 million, resulting in net loss of $0.51 to $0.43 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.85 USD | -1.26% | -2.77% | +14.40% |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
May. 14 | HealthEquity Completes Acquisition of Conduent's BenefitWallet | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.40% | 6.54B | |
+12.51% | 3,144B | |
+12.68% | 88.51B | |
-14.03% | 54.56B | |
+26.21% | 48.26B | |
-22.56% | 47.95B | |
+25.42% | 44.14B | |
+69.48% | 39.42B | |
-8.00% | 25.26B | |
+26.00% | 23.15B |
- Stock Market
- Equities
- HQY Stock
- News HealthEquity, Inc.
- HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023